Categories: EnvironmentalMedtech
Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.
Investors 2
Funding Rounds 1
| Date | Series | Amount | Investors |
| 29.03.2024 | - | $50M | - |
Mentions in press and media 3
| Date | Title | Description |
| 23.09.2024 | Longevity Startups Are Getting Funding, But Not As Fast As We’re Aging | 13 Shares Email Facebook Twitter LinkedIn
We are all getting older. But never before have we been getting this much older.
In the U.S., at least one in six people is now over the age of 65. At the same time, in most developed countries olde... |
| 29.03.2024 | Aeovian Pharmaceuticals Closes $50M Financing | Aeovian Pharmaceuticals, a Berkeley, CA-based clinical-stage biopharmaceutical company, raised $50M in funding.
The round was led by Hevolution with participation from existing investors Apollo Health Ventures, Sofinnova Investments, venBio... |
| - | Aeovian Pharmaceuticals | “Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.” |
Reviews 0
